Misoprostol for the management of postpartum haemorrhage: No benefit if oxytocin is available, but useful where no other alternatives exist

BMJ (Online)

Volumn 343, Issue 7819, 2011, Pages

  Elati, Anisa ^a   Weeks, Andrew ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MISOPROSTOL; OXYTOCIN; PLACEBO; UTEROTONIC AGENT; OXYTOCIC AGENT;

CLINICAL TRIAL (TOPIC); DRUG COST; DRUG EFFICACY; DRUG SAFETY; DRUG SELF ADMINISTRATION; EDITORIAL; HUMAN; MATERNAL MORTALITY; OUTCOME ASSESSMENT; POSTNATAL CARE; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; RISK REDUCTION; RURAL AREA; SHIVERING; FEMALE; PREGNANCY;

FEMALE; HUMANS; MISOPROSTOL; OXYTOCICS; POSTPARTUM HEMORRHAGE; PREGNANCY;

EID: 84859008891     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.d2877     Document Type: Editorial

References (9)

1. Blum J, Alfirevic Z, Walraven G, Weeks A, Winikoff B. Treatment of postpartum hemorrhage with misoprostol. Int J Gynaecol Obstet 2007;99(suppl 2):S202-5. (Pubitemid 350110442)
2. Mousa HA, Alfirevic Z. Treatment for primary postpartum haemorrhage. Cochrane Database Syst Rev 2007;1:CD003249.
3. Potts M, Prata N, Walsh J, Grossman A. Parachute approach to evidence based medicine. BMJ 2006;333:701-3. (Pubitemid 44521019)
4. Winikoff B, Dabash R, Durocher J, Darwish E, Nguyen TN, Leon W, et al. Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women not exposed to oxytocin during labour: a double-blind, randomised, non-inferiority trial. Lancet 2010;375:210-6.
5. Blum J, Winikoff B, Raghavan S, Dabash R, Ramadan MC, Dilbaz B, et al. Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women receiving prophylactic oxytocin: a double-blind, randomised, non-inferiority trial. Lancet 2010;375:217-23.
6. Widmer M, Blum J, Hofmeyr GJ, Carroli G, Abdel-Aleem H, Lumbiganon P, et al. Misoprostol as an adjunct to standard uterotonics for treatment of post-partum haemorrhage: a multicentre, double-blind randomised trial. Lancet 2010;375:1808-13.
7. Gulmezoglu AM, Villar J, Ngoc NT, Piaggio G, Carroli G, Adetoro L, et al. WHO multicentre randomised trial of misoprostol in the management of the third stage of labour. Lancet 2001;358:689-95. (Pubitemid 32823396)
8. Rajbhandari S, Hodgins S, Sanghvi H, McPherson R, Pradhan YV, Baqui AH. Expanding uterotonic protection following childbirth through community-based distribution of misoprostol: operations research study in Nepal. Int J Gynaecol Obstet 2010;108:282-8.
9. Sanghvi H, Ansari N, Prata NJV, Gibson H, Ehsan AT, Smith JM. Prevention of postpartum hemorrhage at home birth in Afghanistan. Int J Gynaecol Obstet 2010;108:276-81.